INS and depressive symptom measurement: Continuation with RAI at 12 months was significantly more likely in patients with baseline A1C values 8.0–9.0% and >9.0% compared with HbA1c <8.0%, cognitive impairment, and depression and in those who added basal insulin during the 12-month follow-up period (Table 3).